These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 2353593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 7. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
    Eiselt J, Veselá E, Racek J.
    Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
    [Abstract] [Full Text] [Related]

  • 9. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 10. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.
    G Ital Nefrol; 2002 Feb; 19(5):552-9. PubMed ID: 12439845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D, Djukanović Lj, Lezajić V.
    Srp Arh Celok Lek; 1992 Feb; 120(9-10):281-5. PubMed ID: 1306020
    [Abstract] [Full Text] [Related]

  • 13. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
    N Engl J Med; 1987 Jan 08; 316(2):73-8. PubMed ID: 3537801
    [Abstract] [Full Text] [Related]

  • 14. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct 08; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 15. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S, Kvasnicka J, Kasl M, Kozlová J, Podrouzek P, Bartûsková J, Válek A.
    Czech Med; 1990 Oct 08; 13(2-3):98-106. PubMed ID: 2245762
    [Abstract] [Full Text] [Related]

  • 16. The effect of high-flux hemodialysis on renal anemia.
    Ayli D, Ayli M, Azak A, Yüksel C, Kosmaz GP, Atilgan G, Dede F, Abayli E, Camlibel M.
    J Nephrol; 2004 Oct 08; 17(5):701-6. PubMed ID: 15593038
    [Abstract] [Full Text] [Related]

  • 17. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
    Acharya VN, Sinha DK, Almeida AF, Pathare AV.
    J Assoc Physicians India; 1995 Aug 08; 43(8):539-42. PubMed ID: 8772973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A, Barreto S, Gimenez E, Labeeuw M, Zech P.
    Clin Nephrol; 1993 Sep 08; 40(3):176-8. PubMed ID: 8403574
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.